NORDIC PHARMA, INC. – Trademark Portfolio

Entity Type: 03

NORDIC PHARMA, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include A, LYSTEDA, LACRIFILL, LACRISEAL, and AMRING PHARMACEUTICALS. The owner is based in BERWYN, PA.